Individual differences in susceptibility to motion sickness among six Skylab astronauts. [electronic resource]
- Acta astronautica
- 155-74 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
0094-5765
10.1016/0094-5765(75)90051-x doi
Acceleration Adrenergic Agents--therapeutic use Aerospace Medicine Coriolis Force Dextroamphetamine--therapeutic use Disease Susceptibility Head Movements--physiology Humans Male Muscarinic Antagonists--therapeutic use Rotation--adverse effects Scopolamine--therapeutic use Space Flight Space Motion Sickness--diagnosis Time Factors Weightlessness--adverse effects